Pearland, TX, United States of America

Jeffrey Dale Hartgerink

This inventor holds 12 USPTO granted patents and 1 published patent application. Top assignees: Northwestern University, William Marsh Rice University, The University of Texas System. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Dale Hartgerink. Retrieved from https://idiyas.com/inventor/jeffrey-dale-hartgerink

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 50.0

Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 223(Granted Patents)


Location History:

  • Houston, TX (US) (2009)
  • Pearland, TX (US) (2008 - 2024)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey Dale Hartgerink

Introduction

Jeffrey Dale Hartgerink is a prominent inventor based in Pearland, Texas, known for his significant contributions to the field of peptide-based hydrogels. With a total of 12 patents to his name, Hartgerink has made remarkable advancements that have implications in various scientific and medical applications.

Latest Patents

Among his latest patents is the development of neutral multidomain peptide hydrogels and their uses. These peptide-based hydrogels, referred to as neutral multidomain peptide hydrogels (NMDP), are designed for encapsulating cells to induce quiescence for long-term storage. They can also be administered to subjects to promote collagen deposition and macrophage infiltration. This innovative hydrogel is particularly useful for the preservation of stem cells, maintaining their quiescence and differentiation potential. Another notable patent involves synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase. This patent includes compositions comprising multidomain peptide hydrogels, which contain peptides with at least one N6-(1-iminoethyl)-lysine side chain. The hydrogels can also incorporate a STING agonist, an immune checkpoint inhibitor, and/or an anti-cancer therapy, providing methods for their use in cancer treatment.

Career Highlights

Hartgerink has had a distinguished career, working at esteemed institutions such as Northwestern University and Rice University. His work has focused on the intersection of materials science and biomedical applications, leading to innovative solutions in the field.

Collaborations

Throughout his career, Hartgerink has collaborated with notable colleagues, including Samuel I. Stupp and Elia Beniash. These collaborations have further enriched his research and contributed to the advancement of peptide-based technologies.

Conclusion

Jeffrey Dale Hartgerink's innovative work in peptide-based hydrogels has positioned him as a leading inventor in his field. His contributions have the potential to significantly impact medical science and tissue engineering.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…